PNC FINANCIAL SERVICES GROUP, INC. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 190 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$819
+290.0%
145
+184.3%
0.00%
Q1 2024$210
-40.7%
51
-39.3%
0.00%
Q4 2023$354
-97.5%
84
-97.5%
0.00%
Q3 2023$14,298
-43.1%
3,310
-13.2%
0.00%
Q2 2023$25,128
-52.7%
3,813
-51.3%
0.00%
Q1 2023$53,119
-21.7%
7,823
-14.8%
0.00%
Q4 2022$67,832
+7.7%
9,179
+46.3%
0.00%
Q3 2022$63,000
-33.7%
6,275
-27.6%
0.00%
Q2 2022$95,000
+61.0%
8,668
+64.9%
0.00%
Q1 2022$59,000
-33.7%
5,255
-7.0%
0.00%
Q4 2021$89,000
+102.3%
5,652
+116.6%
0.00%
Q3 2021$44,000
-35.3%
2,610
-17.5%
0.00%
Q2 2021$68,000
+58.1%
3,165
+12.6%
0.00%
Q1 2021$43,000
+34.4%
2,811
+14.8%
0.00%
Q4 2020$32,000
+88.2%
2,449
+34.9%
0.00%
Q3 2020$17,000
-37.0%
1,815
-22.0%
0.00%
Q2 2020$27,000
+58.8%
2,327
+31.5%
0.00%
Q1 2020$17,000
-66.0%
1,769
-42.4%
0.00%
Q4 2019$50,000
+108.3%
3,073
+74.9%
0.00%
Q3 2019$24,000
-98.7%
1,757
-98.7%
0.00%
-100.0%
Q2 2019$1,873,000
-39.5%
132,903
-21.1%
0.00%
-33.3%
Q1 2019$3,098,000
-65.8%
168,415
-51.5%
0.00%
-70.0%
Q4 2018$9,065,000
+41.3%
346,895
+24.1%
0.01%
+66.7%
Q3 2018$6,414,000
+50.6%
279,485
+25.0%
0.01%
+50.0%
Q2 2018$4,260,000
+11.8%
223,574
-1.1%
0.00%0.0%
Q1 2018$3,812,000
-37.4%
226,168
-43.5%
0.00%
-33.3%
Q4 2017$6,089,000
-2.3%
400,546
+15.0%
0.01%0.0%
Q3 2017$6,235,000
+20.0%
348,350
+9.3%
0.01%0.0%
Q2 2017$5,196,000
+18.3%
318,788
+1.6%
0.01%
+20.0%
Q1 2017$4,393,000
-2.4%
313,802
+11.2%
0.01%0.0%
Q4 2016$4,502,000
+3.1%
282,292
+7.5%
0.01%0.0%
Q3 2016$4,368,000
+39609.1%
262,498
+26149.8%
0.01%
Q2 2016$11,000
+37.5%
1,0000.0%0.00%
Q1 2016$8,000
-11.1%
1,0000.0%0.00%
Q4 2015$9,000
-25.0%
1,000
-5.0%
0.00%
Q3 2015$12,0001,0530.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 728,000$10,425,0005.01%
Signpost Capital Advisors, LP 828,793$11,868,0004.38%
Palo Alto Investors LP 3,786,908$54,229,0003.18%
RTW INVESTMENTS, LP 500,000$7,160,0002.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,139,787$59,282,0002.13%
First Light Asset Management, LLC 229,818$3,291,0001.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 2,461,305$35,246,0001.53%
PURA VIDA INVESTMENTS, LLC 175,000$2,506,0000.92%
WALL STREET ASSOCIATES 655,800$9,391,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 368,390$5,275,0000.90%
View complete list of VANDA PHARMACEUTICALS INC shareholders